Nutraplus
In the Jun 2026 quarter, revenue was under ₹1 Cr in both quarters and net profit was ₹0.02 Cr, against −₹0.01 Cr a year earlier (compared with Jun 2025). Promoters held 40.07% of Nutraplus in Jun 2026, unchanged from Mar 2026.
Peer Comparison
Commodities › Chemicals & Petrochemicals › Commodity Chemicals
| ₹2,354.00 | 32.28 | 69,778 Cr | 4.56 | 0.21% | 13.07% | 14.64% | 17,997 Cr | 2,162 Cr | |
| ₹601.55 | — | 15,325 Cr | 0.72 | 1.84% | -7.73% | -2.69% | 15,521 Cr | -1,971 Cr | |
| ₹1,177.20 | 15.10 | 14,861 Cr | 2.17 | 0.84% | 9.90% | 11.30% | 12,189 Cr | 984 Cr | |
| ₹515.50 | 7.30 | 7,575 Cr | 0.83 | 4.12% | 8.75% | 10.38% | 8,860 Cr | 1,037 Cr | |
| — | 103.79 | 7,489 Cr | 10.36 | 0.13% | 18.80% | 25.38% | 725 Cr | 68 Cr | |
| ₹552.15 | 61.08 | 4,055 Cr | 0.78 | 3.20% | -0.05% | 1.29% | 4,622 Cr | 66 Cr | |
| ₹386.30 | 7.69 | 3,559 Cr | 1.00 | 3.04% | 13.30% | 16.87% | 3,138 Cr | 473 Cr | |
Nutraplus (this company) | — | — | — | — | — | — | — | 0 Cr | -0 Cr |
| Median 8 companies | ₹576.85 | 23.69 | 7,575 Cr | 1.00 | 1.84% | 9.90% | 11.30% | 6,741 Cr | 271 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Weaknesses
1- Company has low interest coverage ratio.
Technical Indicators
Oscillators
Bullish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.01 | 0.01 | 0.03 | 0.02 | 0 | 0 | 0.02 | 0.03 | 0.01 | 0.46 | 0.02 | 0.02 | 0.01 |
| Operating Profit | -0.01 | -0.01 | -0.03 | -0.02 | 0 | 0 | -0.02 | -0.03 | -0.01 | -0.46 | -0.02 | -0.02 | -0.01 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0.06 | 0.03 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.01 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | -0.01 | -0.01 | -0.03 | -0.02 | 0 | 0 | -0.02 | -0.02 | -0.01 | -0.36 | -0.02 | 0.04 | 0.02 |
| Tax % | 0% | 0% | 0% | 0% | — | — | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.01 | -0.01 | -0.03 | -0.02 | 0 | 0 | -0.02 | -0.02 | -0.01 | -0.36 | -0.02 | 0.04 | 0.02 |
| EPS (₹) | 0 | 0 | -0.01 | -0.01 | 0 | 0 | -0.01 | -0.01 | 0 | -0.11 | -0.01 | 0.01 | 0.01 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 65 | 77.51 | 91.05 | 109 | 140 | 107 | 0.02 | 0.1 | -0.06 | 0 | 0 | 0 | 0 |
| Expenses | 61.79 | 65.37 | 92.78 | 99.83 | 127 | 142 | 0.38 | 3.75 | 0.07 | 0.06 | 0.05 | 0.5 | 0.51 |
| Operating Profit | 3.21 | 12.14 | -1.73 | 9.31 | 12.66 | -35.77 | -0.36 | -3.65 | -0.13 | -0.06 | -0.05 | -0.5 | -0.51 |
| OPM % | 4.94% | 15.66% | -1.9% | 8.53% | 9.07% | -33.53% | -1800% | -3650% | — | — | — | — | — |
| Other Income | -2.94 | 1.48 | 0.99 | 0.12 | 1.58 | 0.08 | -23.36 | 0.62 | 0 | 0 | 0 | 0.16 | 0.19 |
| Interest | 4.52 | 4.86 | 5.01 | 4.67 | 6.85 | 7.43 | 0.8 | 0 | 0.03 | 0 | 0 | 0 | 0 |
| Depreciation | 1.4 | 1.72 | 2.21 | 3.88 | 4.03 | 4.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | -5.65 | 7.04 | -7.96 | 0.88 | 3.36 | -47.82 | -24.52 | -3.03 | -0.16 | -0.06 | -0.05 | -0.34 | -0.32 |
| Tax % | -28.14% | -12.64% | -21.36% | 84.09% | 34.82% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Net Profit | -4.06 | 7.93 | -6.26 | 0.14 | 2.19 | -47.83 | -24.52 | -3.03 | -0.16 | -0.06 | -0.05 | -0.34 | -0.32 |
| EPS (₹) | -1.66 | 2.85 | -1.84 | 0.04 | 0.64 | -14.03 | -7.19 | -0.89 | -0.05 | -0.02 | -0.01 | -0.1 | -0.1 |
| Div. Payout % | 0% | 7.99% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11.16 | 12.67 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 |
| Reserves | 36.01 | 50.22 | 50.17 | 50.19 | 52.4 | 4.57 | -19.1 | -22.13 | -22.28 | -22.35 | -22.4 | -22.74 |
| Borrowings | 40.29 | 72.05 | 65.77 | 73.38 | 74.93 | 75.88 | 1.75 | 1.75 | 1.76 | 1.78 | 1.79 | 2.17 |
| Other Liabilities | 26.6 | 30.66 | 37.27 | 31.21 | 25.32 | 39.37 | 34.99 | 12.28 | 8.72 | 8.77 | 8.73 | 8.67 |
| Total Liabilities | 114 | 166 | 170 | 172 | 170 | 137 | 34.69 | 8.95 | 5.25 | 5.25 | 5.17 | 5.15 |
| Fixed Assets | 22.95 | 32.89 | 38.64 | 72.31 | 82.44 | 81.19 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 13.42 | 37.53 | 48.27 | 21.59 | 17.26 | 12.67 | 0.12 | 0 | 0 | 0 | 0 | 0 |
| Investments | 4.2 | 4.15 | 4.16 | 4.15 | 4.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 |
| Other Assets | 73.49 | 91.03 | 79.19 | 73.78 | 65.85 | 42.86 | 34.42 | 8.8 | 5.1 | 5.1 | 5.02 | 5 |
| Total Assets | 114 | 166 | 170 | 172 | 170 | 137 | 34.69 | 8.95 | 5.25 | 5.25 | 5.17 | 5.15 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -16.49 | -9.61 | 19.66 | 6.69 | 12.36 | 9.07 | -14.25 | -0.15 | 0.02 | -0.01 | 0 | -0.39 |
| Investing | -5.1 | -34.42 | -18.59 | -10.7 | -9.74 | -2.69 | 93.77 | 0.12 | 0 | 0 | 0 | 0 |
| Financing | 31.53 | 35.54 | -1.91 | 4 | -2.66 | -7.57 | -80.25 | 0 | -0.03 | 0.02 | 0 | 0.39 |
| Net Cash Flow | 9.94 | -8.48 | -0.84 | -0.01 | -0.03 | -1.18 | -0.73 | -0.03 | -0.01 | 0.01 | 0 | -0.01 |
| Free Cash Flow | -37.12 | -45.37 | 0.96 | -4.13 | 2.5 | 6.24 | 79.49 | -0.03 | 0.02 | -0.01 | 0 | -0.39 |
| CFO/OP | -514 | -72 | -1,139 | 80 | 103 | -26 | 3,958 | 4 | -15 | 17 | 0 | 78 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75.13 | 120 | 105 | 83.71 | 42.97 | 9.48 | 19,710 | 1,898 | — | — | — | — |
| Inventory Days | 134 | 181 | 113 | 111 | 124 | 89.78 | — | 364 | — | — | — | — |
| Days Payable | 186 | 190 | 177 | 133 | 75.89 | 35.11 | — | 879 | — | — | — | — |
| Cash Conversion Cycle | 23.09 | 111 | 40.6 | 61.73 | 91.1 | 64.15 | 19,710 | 1,383 | — | — | — | — |
| Working Capital Days | 60.53 | 117 | 20.61 | 28.43 | 1.99 | -161 | 4,47,855 | 0 | — | — | — | — |
| ROCE % | 2.89% | 9.65% | -2.85% | 4.06% | 8.78% | -33.35% | -0.56% | — | — | — | — | — |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Nutraplus insights
62 extracted metrics + investor summaries across FY09–FY27.
Documents
Frequently Asked Questions about Nutraplus
What does Nutraplus India Ltd do?
Where is Nutraplus India Ltd (NUTRA) listed?
Which sector does Nutraplus India Ltd belong to?
Company Information
Nutraplus India is engaged in the Business of Drugs and Pharmaceuticals.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524764.md for Nutraplus India Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.